MDT

96.14

-0.57%↓

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

MDT

96.14

-0.57%↓

136.19

-1%↓

VEEV

223.11

-0.69%↓

HQY

91.51

-0.5%↓

PHR.US

16.9

-0.59%↓

Home・Akciju saraksts・NeoGenomics Inc

NeoGenomics Inc

Slēgts

11.72 -4.09

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

11.7

Max

12.23

Galvenie mērījumi
By Trading Economics
Ienākumi	18M -27M
Pārdošana	6.5M 188M
Peļņas marža	-14.446
Darbinieki	2,200
EBITDA	38M -10M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+11.14% upside

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	279M 1.6B
Iepriekšējā atvēršanas cena	15.81
Iepriekšējā slēgšanas cena	11.72

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bearish Evidence

7.7 / 10.27 Atbalsts un pretestība

NeoGenomics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 29. dec. 15:14 UTC

Galvenie tirgus virzītāji

Eightco Shares Rise After Buyback Plan of Up to $125 Million

2025. g. 18. dec. 16:36 UTC

Galvenie tirgus virzītāji

SoFi Technologies Shares Rise on Stablecoin Launch

2025. g. 30. dec. 07:54 UTC

Tirgus saruna

Bitcoin's Gains Remain Limited in Holiday Trade -- Market Talk

2025. g. 29. dec. 07:54 UTC

Tirgus saruna

Bitcoin Edges Higher But Recovery Remains Weak -- Market Talk

2025. g. 24. dec. 08:03 UTC

Tirgus saruna

Bitcoin Falls in Holiday-Thinned Trade -- Market Talk

2025. g. 23. dec. 08:07 UTC

Tirgus saruna

Bitcoin Reverses Earlier Gains Ahead of U.S. Data -- Market Talk

2025. g. 22. dec. 13:14 UTC

Tirgus saruna

Bitcoin Rises to One-Week High in Holiday-Thinned Trade -- Market Talk

2025. g. 22. dec. 11:46 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 22. dec. 11:46 UTC

Tirgus saruna

Crypto Market Might Struggle in Near Term -- Market Talk

2025. g. 22. dec. 08:18 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 22. dec. 08:18 UTC

Tirgus saruna

Bitcoin Lifted Higher by Tech Stock Rally -- Market Talk

2025. g. 19. dec. 13:38 UTC

Tirgus saruna

Regulatory Progress Could Lead to More Durable Crypto Recovery in Long Run -- Market Talk

2025. g. 19. dec. 08:15 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 19. dec. 08:15 UTC

Tirgus saruna

Bitcoin Rises After Tech-Led Rally in U.S. Stocks -- Market Talk

2025. g. 18. dec. 15:26 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 18. dec. 15:26 UTC

Tirgus saruna

Potential Digital Euro Needs to Promote Financial Stability, Says ECB's Lagarde -- Market Talk

2025. g. 18. dec. 07:46 UTC

Tirgus saruna

Bitcoin Remains Stuck Below $90K Ahead of Key Data, Rate Decisions -- Market Talk

2025. g. 18. dec. 03:49 UTC

Iegādes, apvienošanās, pārņemšana

Coinbase: Competition Commission of India Approved Proposal to Acquire Minority Stake in CoinDCX

2025. g. 17. dec. 14:20 UTC

Iegādes, apvienošanās, pārņemšana

CIMG Acquired Additional 230 Bitcoin Using Internal Sources of Capital for $24.6M

2025. g. 17. dec. 09:06 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 17. dec. 09:06 UTC

Tirgus saruna

Bitcoin Falls as U.S. Jobs Data Fails to Materially Alter Rate Cut Bets -- Market Talk

2025. g. 16. dec. 18:33 UTC

Tirgus saruna

Bank of Canada Wants Stablecoins to Be 'Good Money' -- Market Talk

2025. g. 16. dec. 12:18 UTC

Iegādes, apvienošanās, pārņemšana

Jiuzi: Matter Remains Subject to Ongoing Negotiations, Framework Arrangements >JZXN

2025. g. 16. dec. 12:17 UTC

Iegādes, apvienošanās, pārņemšana

Jiuzi: Intends to Buy Tokens Issued by Counterparty at Significant Discount Through Private Placement of Co Common Stk, for Total Value of About $1B >JZXN

2025. g. 16. dec. 12:16 UTC

Iegādes, apvienošanās, pārņemšana

Jiuzi Says Co Is in Strategic Cooperation Talks With Web3 Technology Co Specializing in Development of AI Cryptocurrency Trading Platform >JZXN

2025. g. 16. dec. 09:20 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2025. g. 16. dec. 09:12 UTC

Tirgus saruna

SGX's Strong Trading Activity Could Boost FY 2026 Revenue -- Market Talk

2025. g. 16. dec. 09:12 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 16. dec. 08:05 UTC

Tirgus saruna

Bitcoin Falls Ahead of Key U.S. Data, Central Bank Decisions -- Market Talk

2025. g. 15. dec. 14:07 UTC

Tirgus saruna

U.K. Crypto Regulation Could Boost Institutional Participation -- Market Talk

Salīdzinājums

Cenas izmaiņa

NeoGenomics Inc Prognoze

Cenas mērķis

By TipRanks

11.14% augšup

Prognoze 12 mēnešiem

Vidējais 13.67 USD 11.14%

Augstākais 15 USD

Zemākais 12 USD

Pamatojoties uz 11 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi NeoGenomics Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

11 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 11 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam NeoGenomics Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

7.7 / 10.27Atbalsts un pretestība

Recent bearish events outweigh bullish events.

All events are bearish.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.